Interleukin-16 inhibits human immunodeficiency virus type 1 entry and replication in macrophages and in dendritic cells

Journal of Virology

Volumn 73, Issue 8, 1999, Pages 7008-7013

  Truong, Marie Jose ^a   Darcissac, Edith C A ^a   Hermann, Emmanuel ^a   Dewulf, Joelle ^a   Capron, Andre ^a   Bahr, George M ^a  

^a INSTITUT PASTEUR DE LILLE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOATTRACTANT; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR RECEPTOR; INTERLEUKIN 16; MONOKINE; RNA DIRECTED DNA POLYMERASE; VIRUS DNA;

AMINO ACID SEQUENCE; ANIMAL CELL; ANTIGEN PRESENTING CELL; ANTIVIRAL ACTIVITY; ARTICLE; CELL ADHESION; DENDRITIC CELL; HELPER CELL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; PRIORITY JOURNAL; VIRUS REPLICATION;

EID: 0032805883     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.73.8.7008-7013.1999     Document Type: Article

References (31)

1. Akridge, R. E., and S. G. Reed. 1996. Interleukin-12 decreases human immunodeficiency virus type 1 replication in human macrophage cultures reconstituted with autologous peripheral blood mononuclear cells. J. Infect. Dis. 173:559-564.
2. Alkhatib, G., C. Combadiere, C. C. Broder, Y. Feng, P. E. Kennedy, P. M. Murphy, and E. A. Berger. 1996. CC CKR-5: a RANTES, MIP-1a, MIP-1β receptor as a fusion cofactor for macrophage-tropic HIV-1. Science 272: 1955-1958.
3. Amiel, C., E. Darcissac, M. J. Truong, J. Dewulf, M. Loyens, Y. Mouton, A. Capron, and G. M. Bahr. 1999. Interleukin-16 (IL-16) inhibits human immunodeficiency virus replication in cells from infected subjects, and serum IL-16 levels drop with disease progression. J. Infect. Dis. 179:83-91.
4. Baier, M., N. Bannert, A. Werner, K. Lang, and R. Kurth. 1997. Molecular cloning, sequence, expression, and processing of the interleukin 16 precursor. Proc. Natl. Acad. Sci. USA 94:5273-5277.
5. Baier, M., A. Wermer, N. Bannert, K. Metzner, and R. Kurth. 1995. HIV suppression by interleukin-16. Nature 378:563.
6. Center, D. M., H. Kornfeld, and W. W. Cruikshank. 1996. Interleukin 16 and its function as a CD4 ligand. Immunol. Today 17:476-481.
7. Center, D. M., H. Kornfeld, and W. W. Cruikshank. 1997. Interleukin 16. Int. J. Biochem. Cell Biol. 29:1231-1234.
8. Chupp, G. L., E. A. Wright, D. Wu, M. Vallen-Mashikian, W. W. Cruikshank, D. M. Center, H. Kornfeld, and J. S. Berman. 1998. Tissue and T cell distribution of precursor and mature IL-16. J. Immunol. 161:3114-3119.
9. Cruikshank, W. W., H. Kornfeld, and D. M. Center. 1998. Signaling and functional properties of interleukin-16. Int. Rev. Immunol. 16:523-540.
10. Geleziunas, R., N. Morin, and M. A. Wainberg. 1996. Mechanisms of reduction of CD4 receptor expression on the surface of HIV-1 infected cells. C.R. Acad. Sci. Ser. III 319:653-662. (In French.)
11. Henderson, A. J., and K. L. Calame. 1997. CCAAT/enhancer binding protein (C/EBP) sites are required for HIV-1 replication in primary macrophages but not CD4+ T cells. Proc. Natl. Acad. Sci. USA 94:8714-8719.
12. Hermann, E., E. Darcissac, T. Idziorek, A. Capron, and G. M. Bahr. Recombinant interleukin-16 selectively modulates surface receptor expression and cytokine release in macrophages and dendritic cells. Immunology, in press.
13. Idziorek, T., J. Khalife, O. Billaut-Mulot, E. Hermann, M. Aumercier, Y. Mouton, A. Capron, and G. M. Bahr. 1998. Recombinant human interleukin-16 inhibits HIV-1 replication and protects against activation-induced cell death. Clin. Exp. Immunol. 112:84-91.
14. Krautwald, S. 1998. IL-16 activates the SAPK signaling pathway in CD4+ macrophages. J. Immunol. 160:5874-5879.
15. Langhoff, E., E. F. Terwilliger, H. J. Bos, K. H. Kalland, M. C. Poznansky, O. M. L. Bacon, and W. A. Haseltine. 1991. Replication of human immunodeficiency virus type 1 in primary dendritic cell cultures. Proc. Natl. Acad. Sci. USA 88:7998-8002.
16. Legoux, P., C. Minty, B. Delpech, A. J. Minty, and D. Shire. 1992. Simultaneous quantitation of cytokine mRNAs in interleukin-1β stimulated U373 human astrocytoma cells by a polymerisation chain reaction method involving co-amplification with an internal multi-specific control. Eur. Cytokine Netw. 3:553-563.
17. Maciaszek, J. W., N. A. Parada, W. W. Cruikshank, D. M. Center, H. Kornfeld, and G. A. Viglianti. 1997. IL-16 represses HIV-1 promoter activity. J. Immunol. 158:5-8.
18. Meltzer, M. S., D. R. Skillman, P. J. Gomatos, D. C. Kalter, and H. E. Gendelman. 1990. Role of mononuclear phagocytes in the pathogenesis of human immunodeficiency virus infection. Annu. Rev. Immunol. 8:169-194.
19. Neumann, M., J. Harrison, M. Sartarelli, E. Hadziyannis, V. Erfle, B. K. Felber, and G. N. Pavlakis. 1994. Splicing variability in HIV type 1 revealed by quantitative RNA polymerase chain reaction. AIDS Res. Hum. Retroviruses 10:1531-1542.
20. Piatak, M., Jr., K.-C. Luk, B. Williams, and J. D. Lifson. 1993. Quantitative competitive polymerase chain reaction for accurate quantitation of HIV DNA and RNA species. BioTechniques 14:70-81.
21. Ryan, T. C., W. W. Cruikshank, H. Kornfeld, T. L. Collins, and D. M. Center. 1995. The CD4-associated tyrosine kinase p56lck is required for lymphocyte chemoattractant factor-induced T lymphocyte migration. J. Biol. Chem. 270:17081-17086.
22. Sheridan, P. L., C. T. Sheline, K. Cannon, M. L. Voz, M. J. Pazin, J. T. Kadonaga, and K. A. Jones. 1995. Activation of the HIV-1 enhancer by the LEF-1 HMG protein on nucleosome-assembled DNA in vitro. Genes Dev. 9:2090-2104.
23. Stoler, M. H., T. A. Eskin, S. Benn, R. C. Angerer, and L. M. Angerer. 1986. Human T-cell lymphotropic virus type III infection of the central nervous system. A preliminary in situ analysis. JAMA 256:2360-2354.
24. Verani, A., E. Pesenti, S. Polo, E. Tresoldi, G. Scarlatti, P. Lusso, A. G. Siccardi, and D. Vercelli. 1998. CXCR4 is a functional coreceptor for infection of human macrophages by CXCR4-dependent primary isolates. J. Immunol. 161:2084-2088.
25. Viglianti, G. A., N. A. Parada, J. W. Maciaszek, H. Kornfeld, D. M. Center, and W. W. Cruikshank. 1997. IL-16 anti-HIV-1 therapy. Nat. Med. 3:938.
26. Yang, Z., and J. D. Engel. 1993. Human T cell transcription factor GATA-3 stimulates HIV-1 expression. Nucleic Acids Res. 21:2831-2836.
27. Yi, Y., S. Rana, J. D. Turner, N. Gaddis, and R. G. Collman. 1998. CXCR-4 is expressed by primary macrophages and supports CCR5-independent infection by dual-tropic but not T-tropic isolates of human immunodeficiency virus type 1. J. Virol. 72:772-777.
28. Zack, J. A., S. J. Arrigo, S. R. Weitsman, A. S. Go, A. Haislip, and I. S. Chen. 1990. HIV-1 entry into quiescent primary lymphocytes: molecular analysis reveals a labile, latent viral structure. Cell 61:213-222.
29. Zhang, Y., D. M. Center, D. M. Wu, W. W. Cruikshank, J. Yuan, D. W. Andrews, and H. Kornfeld. 1998. Processing and activation of pro-interleukin-16 by caspase-3. J. Biol. Chem. 273:1144-1149.
30. Zhou, L. J., and T. F. Tedder. 1996. CD14+ blood monocytes can differentiate into functionally mature CD83 dendritic cells. Proc. Natl. Acad. Sci. USA 93:2588-2592.
31. Zhou, P., S. Goldstein, K. Devadas, D. Tewari, and A. L. Notkins. 1997. Human CD4+ cells transfected with IL-16 cDNA are resistant to HIV-1 infection: inhibition of mRNA expression. Nat. Med. 3:659-664.